Context
Depression and diabetes mellitus have been associated with an increased risk of all-cause and cardiovascular disease (CVD) mortality. However, data evaluating the joint effects of these 2 conditions on mortality are sparse.
Objectives
To evaluate the individual and joint effects of depression and diabetes on all-cause and CVD mortality rate.
Design
Prospective cohort study.
Setting
The 11 states of the Nurses' Health Study.
Participants
A total of 78 282 women who participated in the Nurses' Health Study aged 54 to 79 years at baseline in 2000 were followed up until 2006. Depression was defined as having self-reported diagnosed depression, treatment with antidepressant medications, or a score indicating severe depressive symptoms (ie, a 5-item Mental Health Index score ≤52). Self-reported type 2 diabetes was confirmed using a supplementary questionnaire.
Main Outcome Measures
All-cause and CVD-specific mortality rate.
Results
During 6 years of follow-up (433 066 person-years), 4654 deaths were documented, including 979 deaths from CVD. Compared with participants without either condition, the age-adjusted relative risks (RRs) (95% confidence interval) for all-cause mortality were 1.76 (1.64-1.89) for women with depression only, 1.71 (1.54-1.89) for individuals with diabetes only, and 3.11 (2.70-3.58) for women with both conditions. The corresponding age-adjusted RRs of CVD mortality were 1.81 (1.54-2.13), 2.67 (2.20-3.23), and 5.38 (4.19-6.91), respectively. These associations were attenuated after multivariate adjustment for other demographic variables, body mass index, smoking status, alcohol intake, physical activity, and major comorbidities (including hypertension, hypercholesterolemia, heart diseases, stroke, and cancer) but remained significant, with the highest RRs for all-cause and CVD mortality found in those with both conditions (2.07 [1.79-2.40] and 2.72 [2.09-3.54], respectively). Furthermore, the combination of depression with a long duration of diabetes mellitus (ie, >10 years) or insulin therapy was associated with a particularly higher risk of CVD mortality after multivariate adjustment (RRs, 3.22 and 4.90, respectively).
Conclusions
Depression and diabetes are associated with a significantly increased risk of all-cause and CVD mortality rate. The coexistence of these conditions identifies women at particularly high risk.
Depression is highly prevalent in the US population, affecting approximately 14.8 million US adults (6.7%) in a given year.1 Strong evidence from epidemiologic studies suggests that depression is associated with a significantly increased risk of coronary heart disease2 and all-cause mortality.3 Diabetes mellitus is also highly prevalent, and more than 23.5 million US adults (10%) have this disorder.4 It is also well known that diabetes and its related complications are leading causes of mortality globally.5
Epidemiologic studies have consistently documented an increased prevalence of depression in patients with diabetes. It is estimated that clinically significant depressive symptoms affect approximately 20% to 25% of individuals with diabetes, nearly twice as many as those without diabetes.6 The coexistence of diabetes and depression is known to be associated with poor glycemic control,7 an increased risk of diabetes complications,8 and poor adherence to diabetes management.9 A growing body of evidence suggests that the combination of diabetes and depression could substantially increase the risk of mortality.10-17 However, previous investigations have been limited by small sample size,10,13,15 short-term follow-up,14-16 evaluation only in patients with diabetes (with no comparison group of patients without diabetes),13-15,17 and the use of self-reported, questionnaire-derived depressive symptoms as the exposure (with no information regarding depression diagnosis and medication use).11-13,17 In addition, few studies have been conducted among women, in whom depression is more prevalent than in men.18 Therefore, using data from the Nurses' Health Study, we aimed to examine the individual and joint effects of depression and type 2 diabetes on all-cause and cardiovascular disease (CVD) mortality rate among middle-aged and elderly women during a 6-year follow-up.
The Nurses' Health Study cohort was established in 1976, when 121 700 female registered nurses aged 30 to 55 years residing in 11 states responded to a mailed questionnaire regarding their medical history and health practices. The cohort has been followed up every 2 years with mailed questionnaires that updated exposure information and inquired about newly diagnosed medical illnesses. Details have been published elsewhere.2,19 Until 2006, the follow-up rate was more than 94%. The study protocol was approved by the institutional review boards of the Brigham and Women's Hospital and Harvard School of Public Health.
We used the 2000 questionnaire cycle as the baseline because self-reported diagnosed depression was addressed in this year (n = 94 791). Participants with a history of gestational diabetes (n = 339); type 1 diabetes (n = 310); secondary diabetes (n = 360); no information on depressive symptoms, depression diagnosis, or antidepressant use (n = 12 041); unknown diabetes diagnosis date or uncertainty of the diagnosis (n = 3361); and missing values for covariates (n = 98) at baseline were excluded. Therefore, 78 282 participants (aged 54 to 79 years) were included in this analysis.
Self-reported symptoms of depression, use of antidepressant medication, and physician-diagnosed depression were used as measures of depression. Depressive symptoms were assessed in 1992, 1996, and 2000 with the 5-item Mental Health Index (MHI-5) subscale of the 36-Item Short-Form Health Survey designed to capture psychological distress vs well-being.20-22 The participants were asked how much of the time during the past month (all, most, a good bit, some, little, or none) they felt (1) nervous, (2) so down that nothing could cheer them up, (3) calm and peaceful, (4) down and blue, or (5) happy. The scale was scored from 0 to 100, with lower scores indicating more severe depressive symptoms (SDS). The MHI-5 has been shown to have high sensitivity and specificity for major depression, with an area under the receiver operating characteristic curve of 0.88 to 0.91 for the detection of major depressive disorder.23 In accordance with a prior study coauthored by 2 of us19 that used this scale, the MHI-5 score was considered a dichotomous indicator of the presence (MHI-5 score, ≤52) or absence (MHI-5 score, >52) of SDS.
Participants were first asked to report regular antidepressant medication use in 1996 and history of physician-diagnosed depression in 2000; hence, 2000 was used as the baseline for this study. The information regarding antidepressant medication and physician-diagnosed depression was updated biennially. Therefore, depression was defined as having diagnosed depression, being treated with antidepressant medications, having SDS, or having any of these conditions.
A supplementary questionnaire regarding symptoms, diagnostic tests, and hypoglycemic therapy was mailed to women who indicated on any biennial questionnaire that they had been diagnosed as having diabetes. Several repeated mailings were sent to nonrespondents, and these were followed up by telephone interviews. A case of diabetes was considered confirmed if at least 1 of the following was reported on the supplementary questionnaire according to the National Diabetes Data Group criteria24: (1) the presence of 1 or more classic symptoms (excessive thirst, polyuria, weight loss, and/or hunger) plus fasting plasma glucose levels of at least 140 mg/dL or random plasma glucose levels of at least 200 mg/dL (to convert glucose levels to millimoles per liter, multiply by 0.0555); (2) at least 2 elevated plasma glucose concentrations on different occasions (fasting levels of at least 140 mg/dL, random plasma glucose levels of at least 200 mg/dL, and/or concentrations of at least 200 mg/dL after 2 hours or more shown by oral glucose tolerance testing) in the absence of symptoms; or (3) treatment with hypoglycemic medication (insulin or oral hypoglycemic agent). For cases of type 2 diabetes identified after June 1996, the cutoff point was lowered to 126 mg/dL for fasting plasma glucose concentrations, according to the American Diabetes Association criteria.25 The self-reported type 2 diabetes diagnosis through supplemental questionnaire confirmation has been demonstrated to be highly accurate in a validation study conducted in a subsample of Nurses' Health Study participants, which consisted of comparisons with medical record review by an endocrinologist (J.E.M.).26 In addition, another validation study27 assessing the prevalence of undiagnosed diabetes suggested a low rate of false-negative results.
The main outcome measures were all-cause and CVD-specific mortality that occurred after the return of the 2000 questionnaire but before June 1, 2006. The ascertainment of death has been documented in previous studies.2,28 Briefly, deaths were identified by reports from next of kin, postal authorities, or searching the National Death Index, and at least 98% of deaths were identified.29 We obtained copies of death certificates and medical records and determined causes of death (classified according to the categories of the International Classification of Diseases, Revision 8 (ICD-8). Fatal CVD was confirmed by hospital records or autopsy or if CVD was listed as the cause of death on the death certificate and evidence of previous CVD was available. Probable fatal CVD cases were designated when CVD was the underlying cause on the death certificate but no medical records were available. We also included sudden deaths (5.4% of CVD death). Deaths of all CVD causes included ICD-8 codes 390 through 459 and 795.28
Demographic, lifestyle behavior, and comorbidity information were collected using the standardized questionnaires mailed to the nurses biennially. Marital status (having a spouse or not), ethnicity (white or other), family history (in the first-degree relatives) of diabetes (yes or no) and cancer (yes or no), and parental history of myocardial infarction (yes or no) were obtained. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared from self-reported weight and height and categorized as less than 23, 23.0 through 24.9, 25.0 through 29.9, 30.0 through 34.9, or 35 or higher. Physical activity level based on the individual's engagement in usual recreational activity was grouped as less than 3,
3.0 through 8.9, 9.0 through 17.9, 18.0 through 26.9, or 27 or more metabolic equivalent hours per week. Smoking was grouped as never, former, or current smoker, and alcohol drinking status was categorized as 0, 0.1 through 4.9, or 5.0 or more g/d of alcohol. Most of the women were postmenopausal or in the perimenopausal period; information regarding estrogen hormone therapy was queried, and participants were categorized as never, former, or current users. Information regarding current aspirin and multivitamin use was also requested and grouped as yes or no. In addition, respondents were asked to report previously diagnosed medical conditions, including hypertension, elevated cholesterol level, heart disease, stroke, and cancer.
Participants were classified into 4 groups: (1) without diabetes or depression, set as the reference group; (2) with depression but no diabetes; (3) with diabetes but no depression; and (4) with diabetes and depression. Means or proportions of covariates across the 4 groups were computed using the baseline information. For these comparisons, we used Mantel-Haenszel χ2 tests for categorical variables and analysis of variance for continuous variables. Person-years for each participant were calculated from the date the 2000 questionnaire was returned to the date of death from any cause; June 1, 2006; or the date of return of their last questionnaire, whichever came first. Time-dependent Cox proportional hazards models were used to estimate age- and multivariate-adjusted relative risks (RRs) of mortality for each group compared with the reference group. The basic model used the updated depression and diabetes status and included age (continuous), marital status, family history of diabetes and cancer, and parental history of myocardial infarction. The multivariate model included the terms in the basic model and several major lifestyle variables: BMI, physical activity level, smoking and drinking status, use of estrogen hormone therapy, current aspirin use, and current multivitamin use. Major comorbidities (updated status of hypertension, elevated cholesterol level, heart disease, stroke, and cancer) were included in another multivariate model to explore whether the effects of diabetes and depression were independent of these comorbidities, which were more likely to be mediators. All the covariates except family history of diabetes and cancer and parental history of myocardial infarction were updated every 2 years.
A series of stratified analyses were conducted by age, BMI, smoking status, alcohol intake status, physical activity level, postmenopausal estrogen hormone use, and prior hypertension, hypercholesterolemia, heart disease, stroke, and cancer, all using updated information. Several complementary analyses were conducted to assess the robustness of the depression definition. The first analysis used only SDS to define depression and used the information from 1992 to 2006, the second defined depression based on antidepressant medication use and used the information from 1996 to 2006, and the third used
only self-reported diagnosed depression from 2000 to 2006. We also conducted subgroup analysis according to duration or treatment of diabetes. The associations of different stages of depression (only SDS, only diagnosed depression, or using antidepressant medication) and the effect of their combination with diabetes on mortality risk were further examined. All reported P values were 2-sided, and statistical analyses were performed with SAS statistical software, version 9.1 (SAS Institute Inc, Cary, North Carolina).
During the 6-year follow-up of these 78 282 middle-aged and elderly women (433 066 person-years), 4654 deaths (6.0%) were documented, with CVD mortality accounting for 979 (21.0%) of all deaths. Generally, participants with diabetes and depression combined had lower MHI-5 scores and physical activity levels, had higher BMIs, and were less likely to have spouses at baseline compared with the other 3 groups (Table 1). In addition, they had higher rates of other comorbidities, including histories of hypertension, heart disease, stroke, or cancer at baseline (Table 1). The prevalence of depression in participants with diabetes (20.5%) was higher than that in the individuals without diabetes (15.1%).
Analyses according to updated status of diabetes and depression
Compared with the reference group who had neither diabetes nor depression, the age-adjusted RR for all-cause mortality was more than 3-fold higher in those with both conditions (RR, 3.11; 95% confidence interval [CI], 2.70-3.58) (Table 2). Multivariate adjustment did not substantially modify the results, with RRs of 1.53 (95% CI, 1.42-1.64) for those with depression only, 1.52 (95% CI, 1.36-1.69) for those with diabetes only, and 2.46 (95% CI, 2.12-2.84) for those with diabetes and depression. Similar results were found with regard to CVD-specific mortality rate. Compared with the reference group, depression only and diabetes only alone showed a significantly increased risk of CVD mortality, with multivariate-adjusted RRs of 1.56 (95% CI, 1.33-1.84) and 2.15 (95% CI, 1.76-2.64), respectively. The RR for individuals with both conditions was 3.89 (95% CI, 3.00-5.05; P for interaction = .49).
All the associations were substantially attenuated after controlling for some major comorbidities (updated status of hypertension, hypercholesterolemia, heart disease, stroke, and cancer) but remained significant. Compared with the reference group who had neither condition, the RRs of total and CVD mortality for individuals with both conditions decreased to 2.07 (95% CI, 1.79-2.40) and 2.72 (2.09-3.54). However, adjustment for major comorbidities might be overadjustment to some extent because depression and diabetes are strong risk factors for those comorbidities, particularly CVD.30,31
In subgroup analyses (Table 3), the excess risk of CVD mortality associated with diabetes only, depression only, or both conditions was significant in most stratified subgroups. The magnitudes of the RRs varied across different stratifications, whereas the pattern was comparable with the highest RRs found in those with both conditions. The results from the complementary analyses (using different definition of depression and periods) were consistent with the main analysis (Table 4).
Effect of diabetes duration and treatment and depression on cvd mortality rate
As expected, the risk of CVD mortality increased monotonically with increased duration of clinical diabetes. Compared
with women without diabetes, the multivariate-adjusted RRs of CVD death across categories of diabetes duration (<5, 5-10, and >10 years) were 0.95 (95% CI, 0.66-1.37), 1.75 (95% CI, 1.30-2.37), and 2.40 (95% CI, 1.94-2.97), respectively (data not shown). In the same multivariate model, the RR of CVD mortality for women with depression was 1.54 (95% CI, 1.29-1.83) compared with those without (data not shown). Among each stratum of duration of diabetes, the presence of depression implied a significantly higher risk compared with those without depression (Figure, A). The combination of depression and a long duration of diabetes (ie, >10 years) was associated with a RR of 3.22 (95% CI, 2.29-4.52) compared with those with neither diabetes nor depression.
The multivariate RRs of CVD death across categories of diabetes treatment (no treatment, oral diabetes medication use, and insulin therapy) were 1.12 (95% CI, 0.78-1.52), 1.58 (95% CI, 1.26-1.99), and 3.11 (95% CI, 2.41-4.01), respectively (data not shown). The combination of depression and insulin therapy was associated with an approximate 4.90-fold (95% CI, 3.35-7.15) increased risk of CVD death compared with those with neither diabetes nor depression (Figure, B).
Effect of depression categories and diabetes on cvd mortality rate
The increased risk of CVD mortality was evident in each stage of depression. Compared with participants without depression, the multivariate-adjusted RRs of CVD death in each category of depression (SDS only, diagnosed depression without treatment only, and antidepressant medication use) were 1.73 (95% CI, 1.28-2.33), 1.27 (95% CI, 0.97-1.67), and 1.42 (95% CI, 1.19-1.69),
respectively (data not shown). Participants with SDS and diabetes combined had the highest RR of 4.54 (95% CI, 2.60-7.92) on death of CVD compared with those who had neither condition (Figure, C).
In this large prospective cohort of women, we confirmed that diabetes and depression were significant risk factors for all-cause and CVD mortality, whereas the coexistence of these conditions was associated with a much higher risk. We also observed a strong monotonic relation between diabetes severity (diabetes duration or type of treatment) and CVD mortality rate, with highest risk among women with higher diabetes severity and comorbid depression combined.
Compared with individuals without diabetes, the risk of death in women with diabetes was increased by 35.2% in the current study. This is slightly lower but consistent with several previous publications32-35 in which a 1.5- to 2-fold increased risk of death was reported. However, it is slightly lower than a previous report coauthored by 3 of us28 in this cohort in which a 2.5-fold increased risk of all-cause mortality was observed for women with diabetes during 20 years of follow-up (1976-1996). The discrepancy might be because of shorter duration of follow-up, secular trends in treatment for diabetes and cardiovascular disease, and age differences in the present study. We also confirmed that diabetes was a leading cause of CVD mortality with a multivariate adjusted RR of 1.67. This finding is consistent with most previous publications summarized in 2 meta-analyses.36,37 In addition, we found that the risk of all-cause and CVD death was approximately 40% higher in women with depression compared with individuals without depression, which is consistent with findings of other investigators3,38 and a prior publication in the same cohort coauthored by 1 of us,2 in which a 1.54-fold increased risk of fatal coronary heart disease associated with depression was observed.
We further observed that the coexistence of diabetes and depression was associated with a much higher risk of all-cause mortality (RR, 2.07). Egede and colleagues11 also found similar results, with a 2.5-fold increased mortality risk for the combination of diabetes and depression compared with those without either condition. Black et al10 observed a much higher risk of the diabetes-depression combination with an RR of 4.94, which might occur because of using a reference group with neither diabetes nor depressive symptoms (Center for Epidemiologic Study of Depression score of 0 instead of the commonly used cutoff point of 1639). It could also occur because of differences in the study populations. The study by Black et al comprised Mexican Americans 65 years or older, whereas our study included primarily white women.
In our multivariate-adjusted model, we also found that the diabetes-and-depression combination was associated with a 2.7-fold increased risk of CVD mortality compared with those who had neither condition. This risk was much higher than that owing to diabetes (RR, 1.67) or depression
(RR, 1.37) only. Egede et al11 observed similar risks of coronary heart disease mortality among participants with both conditions (RR, 2.43) and those with diabetes only (RR, 2.26). However, they used a Center for Epidemiologic Study of Depression score of 16 to categorize depression status, which might represent less severe depressive symptoms than clinical diagnosis. In our study, the formal interaction test was not statistically significant, suggesting that the joint effects of diabetes and depression on CVD mortality rate are likely to be additive. Nevertheless, the RR (2.72) was still moderately higher than the additive risk (1.67 × 1.37 = 2.29). Depression affects approximately 20% to 25% of the diabetic population6; therefore, considering the size of the potential populations affected, the excess risk of all-cause and CVD death associated with depression among individuals with type 2 diabetes deserves additional attention.
The underlying mechanisms of the increased mortality risk associated with depression in patients with diabetes remain to be elucidated. Numerous studies have found that depression and diabetes are highly correlated40 and the association is bidirectional.41 It is generally suggested that depression is associated with poor glycemic control,7 an increased risk of diabetes complications,8 poor adherence to diabetes management by patients,9 and isolation from the social network.42 Diabetes and depression are linked to unhealthy behaviors (such as tobacco use, poor diet quality, sedentary lifestyle, and inadequate exercise),43,44 and these behaviors are particularly prevalent in individuals with both conditions. With regard to CVD death, depression could trigger episodes of transient ischemia,45 increase hypothalamic-pituitary-adrenal axis activity and sympathetic nervous system tone, decrease heart rate variability and the cardiac fibrillation threshold, and alter thrombogenesis.46,47 Alterations in platelet serotonin receptors and increased catecholamine and serotonin levels associated with depression may also promote platelet clumping and subsequent thrombosis.48
Ours is one of few cohort studies that investigated the joint effect of diabetes and depression on all-cause and CVD-specific mortality rate among women. The large sample size and long duration of follow-up provide the opportunity to examine the association of diabetes and depression by themselves and in combination with risk of mortality. The follow-up rate of this well-established cohort was high (>94.0%), and more than 98.0% of the deaths were ascertained. Thus, our study results are unlikely to be biased by losses to follow-up. In addition, we have collected detailed information on disease assessments (diabetes, depression, and related comorbidities) and other risk factors, such as smoking, BMI, and physical activity through repeated assessments.
Several limitations of the study should be considered. The study sample was a homogeneous population, all the participants were registered nurses, and more than 97.6% of participants were white. They had greater concern about their health and better understanding of health-related issues, which enhanced the reliability of our questionnaire assessment; however, the results might not be generalizable to other populations. Recruitment bias and survival bias of the cohort might also restrict the generalizability. In addition, the information regarding diagnosed diabetes and depression was based on self-report, and the exact diagnosis date of depression was not available. This may lead to some misclassification of the exposure variables. However, previous studies coauthored by 2 of us26,27 have found self-reporting of diabetes to be highly reliable, although undiagnosed diabetes was possible in this cohort. On the other hand, the physician recognition rate of major depression is not generally considered to be high compared with the Structured Clinical Interview for DSM-IV,49 and the prevalence of untreated mental disorders is relatively high in the United States.50 Therefore, history of depression is likely to be underreported, which might have led to an overestimation of the risk in the depression-free population. Furthermore, we did not have information regarding medication adherence, glycemic control, diabetes complications, and disability levels, restricting our ability to explore the underlying mechanisms.
The comorbidity of depression and diabetes is associated with a substantial increase in the risk of mortality, particularly death from CVD. Considering the size of the population that could be affected by these 2 prevalent disorders, further consideration is required to design strategies aimed to provide adequate psychological management and support among those with longstanding chronic conditions, such as diabetes.
Correspondence: Frank B. Hu, MD, PhD, Department of Nutrition, Harvard School of Public Health, 655 Huntington Ave, Boston, MA 02115 (frank.hu@channing.harvard.edu).
Submitted for Publication: April 16, 2010; final revision received June 13, 2010; accepted August 10, 2010.
Author Contributions: Drs Pan, Lucas, Franco, Willett, Manson, Rexrode, Ascherio, and Hu had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Financial Disclosure: None reported.
Funding/Support: The study was supported by National Institutes of Health grant DK58845. Dr Ascherio received a grant from the National Alliance for Research on Schizophrenia & Depression (project 5048070-01). Dr Lucas received a postdoctoral fellowship from the Fonds de recherche en santé du Québec.
Role of the Sponsor: The funding sources were not involved in the data collection, data analysis, manuscript writing, and publication.
Additional Information: We thank the participants in the Nurses' Health Study for their continuing support and colleagues who worked on the study for their valuable help.
1.Kessler
RCChiu
WTDemler
OMerikangas
KRWalters
EE Prevalence, severity, and comorbidity of 12-month
DSM-IV disorders in the National Comorbidity Survey Replication.
Arch Gen Psychiatry 2005;62
(6)
617- 627
PubMedGoogle Scholar 2.Whang
WKubzansky
LDKawachi
IRexrode
KMKroenke
CHGlynn
RJGaran
HAlbert
CM Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study.
J Am Coll Cardiol 2009;53
(11)
950- 958
PubMedGoogle Scholar 3.Cuijpers
PSmit
F Excess mortality in depression: a meta-analysis of community studies.
J Affect Disord 2002;72
(3)
227- 236
PubMedGoogle Scholar 4.Centers for Disease Control and Prevention,
national diabetes fact sheet: general information and national estimates on diabetes in the United States 2007;Centers for Disease Control and Prevention Web site.
http://www.cdc.gov/diabetes/pubs/factsheet07.htm16 January2010;
5.Mathers
CDLoncar
D Projections of global mortality and burden of disease from 2002 to 2030.
PLoS Med 2006;3
(11)
e442
PubMed10.1371/journal.pmed.003042
Google Scholar 6.Anderson
RJFreedland
KEClouse
RELustman
PJ The prevalence of comorbid depression in adults with diabetes: a meta-analysis.
Diabetes Care 2001;24
(6)
1069- 1078
PubMedGoogle Scholar 7.Lustman
PJAnderson
RJFreedland
KEde Groot
MCarney
RMClouse
RE Depression and poor glycemic control: a meta-analytic review of the literature.
Diabetes Care 2000;23
(7)
934- 942
PubMedGoogle Scholar 8.de Groot
MAnderson
RFreedland
KEClouse
RELustman
PJ Association of depression and diabetes complications: a meta-analysis.
Psychosom Med 2001;63
(4)
619- 630
PubMedGoogle Scholar 9.Gonzalez
JSPeyrot
MMcCarl
LACollins
EMSerpa
LMimiaga
MJSafren
SA Depression and diabetes treatment nonadherence: a meta-analysis.
Diabetes Care 2008;31
(12)
2398- 2403
PubMedGoogle Scholar 10.Black
SAMarkides
KSRay
LA Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes.
Diabetes Care 2003;26
(10)
2822- 2828
PubMedGoogle Scholar 11.Egede
LENietert
PJZheng
D Depression and all-cause and coronary heart disease mortality among adults with and without diabetes.
Diabetes Care 2005;28
(6)
1339- 1345
PubMedGoogle Scholar 12.Zhang
XNorris
SLGregg
EWCheng
YJBeckles
GKahn
HS Depressive symptoms and mortality among persons with and without diabetes.
Am J Epidemiol 2005;161
(7)
652- 660
PubMedGoogle Scholar 13.Bruce
DGDavis
WAStarkstein
SEDavis
TM A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study.
Diabetologia 2005;48
(12)
2532- 2539
PubMedGoogle Scholar 14.Katon
WJRutter
CSimon
GLin
EHLudman
ECiechanowski
PKinder
LYoung
BVon Korff
M The association of comorbid depression with mortality in patients with type 2 diabetes.
Diabetes Care 2005;28
(11)
2668- 2672
PubMedGoogle Scholar 15.Ismail
KWinkley
KStahl
DChalder
TEdmonds
M A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality.
Diabetes Care 2007;30
(6)
1473- 1479
PubMedGoogle Scholar 16.Katon
WFan
MYUnützer
JTaylor
JPincus
HSchoenbaum
M Depression and diabetes: a potentially lethal combination.
J Gen Intern Med 2008;23
(10)
1571- 1575
PubMedGoogle Scholar 17.Lin
EHHeckbert
SRRutter
CMKaton
WJCiechanowski
PLudman
EJOliver
MYoung
BAMcCulloch
DKVon Korff
M Depression and increased mortality in diabetes: unexpected causes of death.
Ann Fam Med 2009;7
(5)
414- 421
PubMedGoogle Scholar 19.Arroyo
CHu
FBRyan
LMKawachi
IColditz
GASpeizer
FEManson
J Depressive symptoms and risk of type 2 diabetes in women.
Diabetes Care 2004;27
(1)
129- 133
PubMedGoogle Scholar 20.McHorney
CAWare
JE
JrLu
JFSherbourne
CD The MOS 36-Item Short-Form Health Survey (SF-36): III: tests of data quality, scaling assumptions, and reliability across diverse patient groups.
Med Care 1994;32
(1)
40- 66
PubMedGoogle Scholar 21.McHorney
CAWare
JE
JrRaczek
AE The MOS 36-Item Short-Form Health Survey (SF-36): II: psychometric and clinical tests of validity in measuring physical and mental health constructs.
Med Care 1993;31
(3)
247- 263
PubMedGoogle Scholar 22.Ware
JE
JrSherbourne
CD The MOS 36-Item Short-Form Health Survey (SF-36): I: conceptual framework and item selection.
Med Care 1992;30
(6)
473- 483
PubMedGoogle Scholar 23.Berwick
DMMurphy
JMGoldman
PAWare
JE
JrBarsky
AJWeinstein
MC Performance of a five-item mental health screening test.
Med Care 1991;29
(2)
169- 176
PubMedGoogle Scholar 24.National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
Diabetes 1979;28
(12)
1039- 1057
PubMedGoogle Scholar 25.Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus.
Diabetes Care 1997;20
(7)
1183- 1197
PubMedGoogle Scholar 26.Manson
JERimm
EBStampfer
MJColditz
GAWillett
WCKrolewski
ASRosner
BHennekens
CHSpeizer
FE Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.
Lancet 1991;338
(8770)
774- 778
PubMedGoogle Scholar 27.Field
AECoakley
EHMust
ASpadano
JLLaird
NDietz
WHRimm
EColditz
GA Impact of overweight on the risk of developing common chronic diseases during a 10-year period.
Arch Intern Med 2001;161
(13)
1581- 1586
PubMedGoogle Scholar 28.Hu
FBStampfer
MJSolomon
CGLiu
SWillett
WCSpeizer
FENathan
DMManson
JE The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up.
Arch Intern Med 2001;161
(14)
1717- 1723
PubMedGoogle Scholar 29.Rich-Edwards
JWCorsano
KAStampfer
MJ Test of the National Death Index and Equifax Nationwide Death Search.
Am J Epidemiol 1994;140
(11)
1016- 1019
PubMedGoogle Scholar 30.Nicholson
AKuper
HHemingway
H Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies.
Eur Heart J 2006;27
(23)
2763- 2774
PubMedGoogle Scholar 31.Lloyd-Jones
DAdams
RJBrown
TMCarnethon
MDai
SDe Simone
GFerguson
TBFord
EFurie
KGillespie
CGo
AGreenlund
KHaase
NHailpern
SHo
PMHoward
VKissela
BKittner
SLackland
DLisabeth
LMarelli
AMcDermott
MMMeigs
JMozaffarian
DMussolino
MNichol
GRoger
VLRosamond
WSacco
RSorlie
PRoger
VLStafford
RThom
TWasserthiel-Smoller
SWong
NDWylie- Rosett
JAmerican Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics—2010 update: a report from the American Heart Association [corrected in
Circulation. 2010;121(12):e260].
Circulation 2010;121
(7)
e46- e215
PubMed10.1161/CIRCULATIONAHA.109.192667
Google Scholar 32.Gu
KCowie
CCHarris
MI Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993.
Diabetes Care 1998;21
(7)
1138- 1145
PubMedGoogle Scholar 33.Lotufo
PAGaziano
JMChae
CUAjani
UAMoreno-John
GBuring
JEManson
JE Diabetes and all-cause and coronary heart disease mortality among US male physicians.
Arch Intern Med 2001;161
(2)
242- 247
PubMedGoogle Scholar 34.Cho
ERimm
EBStampfer
MJWillett
WCHu
FB The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men.
J Am Coll Cardiol 2002;40
(5)
954- 960
PubMedGoogle Scholar 35.Saydah
SHEberhardt
MSLoria
CMBrancati
FL Age and the burden of death attributable to diabetes in the United States.
Am J Epidemiol 2002;156
(8)
714- 719
PubMedGoogle Scholar 36.Lee
WLCheung
AMCape
DZinman
B Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies.
Diabetes Care 2000;23
(7)
962- 968
PubMedGoogle Scholar 37.Huxley
RBarzi
FWoodward
M Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.
BMJ 2006;332
(7533)
73- 78
PubMedGoogle Scholar 38.Wassertheil-Smoller
SShumaker
SOckene
JTalavera
GAGreenland
PCochrane
BRobbins
JAragaki
ADunbar-Jacob
J Depression and cardiovascular sequelae in postmenopausal women: the Women's Health Initiative (WHI).
Arch Intern Med 2004;164
(3)
289- 298
PubMedGoogle Scholar 39.Radloff
L The CES-D scale: a self-report depression scale for research in the general population.
Appl Psychol Meas 1977;1
(3)
385- 401
Google Scholar 40.Mezuk
BEaton
WWAlbrecht
SGolden
SH Depression and type 2 diabetes over the lifespan: a meta-analysis.
Diabetes Care 2008;31
(12)
2383- 2390
PubMedGoogle Scholar 41.Golden
SHLazo
MCarnethon
MBertoni
AGSchreiner
PJDiez Roux
AVLee
HBLyketsos
C Examining a bidirectional association between depressive symptoms and diabetes.
JAMA 2008;299
(23)
2751- 2759
PubMedGoogle Scholar 43.Strine
TWMokdad
AHDube
SRBalluz
LSGonzalez
OBerry
JTManderscheid
RKroenke
K The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults.
Gen Hosp Psychiatry 2008;30
(2)
127- 137
PubMedGoogle Scholar 44.Katon
WJRusso
JEHeckbert
SRLin
EHCiechanowski
PLudman
EYoung
BVon Korff
M The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes.
Int J Geriatr Psychiatry 2010;25
(5)
466- 475
PubMedGoogle Scholar 45.Jiang
WBabyak
MKrantz
DSWaugh
RAColeman
REHanson
MMFrid
DJMcNulty
SMorris
JJO’Connor
CMBlumenthal
JA Mental stress–induced myocardial ischemia and cardiac events.
JAMA 1996;275
(21)
1651- 1656
PubMedGoogle Scholar 46.Carney
RMFreedland
KERich
MWJaffe
AS Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms.
Ann Behav Med 1995;17
(2)
142- 149
PubMedGoogle Scholar 47.Carney
RMSaunders
RDFreedland
KEStein
PRich
MWJaffe
AS Association of depression with reduced heart rate variability in coronary artery disease.
Am J Cardiol 1995;76
(8)
562- 564
PubMedGoogle Scholar 48.Schins
AHonig
ACrijns
HBaur
LHamulyák
K Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?
Psychosom Med 2003;65
(5)
729- 737
PubMedGoogle Scholar 49.Löwe
BSpitzer
RLGräfe
KKroenke
KQuenter
AZipfel
SBuchholz
CWitte
SHerzog
W Comparative validity of three screening questionnaires for
DSM-IV depressive disorders and physicians' diagnoses.
J Affect Disord 2004;78
(2)
131- 140
PubMedGoogle Scholar 50.Demyttenaere
KBruffaerts
RPosada-Villa
JGasquet
IKovess
VLepine
JPAngermeyer
MCBernert
Sde Girolamo
GMorosini
PPolidori
GKikkawa
TKawakami
NOno
YTakeshima
TUda
HKaram
EGFayyad
JAKaram
ANMneimneh
ZNMedina-Mora
MEBorges
GLara
Cde Graaf
ROrmel
JGureje
OShen
YHuang
YZhang
MAlonso
JHaro
JMVilagut
GBromet
EJGluzman
SWebb
CKessler
RCMerikangas
KRAnthony
JCVon Korff
MRWang
PSBrugha
TSAguilar-Gaxiola
SLee
SHeeringa
SPennell
BEZaslavsky
AMUstun
TBChatterji
SWHO World Mental Health Survey Consortium, Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.
JAMA 2004;291
(21)
2581- 2590
PubMedGoogle Scholar